X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare INDRAPRASTHA MEDICAL with FORTIS HEALTHCARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL vs FORTIS HEALTHCARE - Comparison Results

FORTIS HEALTHCARE 
   Change

Fortis Healthcare was established in 1996 by the promoters of Ranbaxy Laboratories, India's largest pharmaceutical company. It is one of the largest private healthcare companies in India based on the number of hospital beds, according to Crisil. The ... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDRAPRASTHA MEDICAL FORTIS HEALTHCARE INDRAPRASTHA MEDICAL/
FORTIS HEALTHCARE
 
P/E (TTM) x 17.7 13.8 128.4% View Chart
P/BV x 2.6 1.7 155.6% View Chart
Dividend Yield % 3.3 0.0 -  

Financials

 INDRAPRASTHA MEDICAL   FORTIS HEALTHCARE
EQUITY SHARE DATA
    INDRAPRASTHA MEDICAL
Mar-14
FORTIS HEALTHCARE
Mar-16
INDRAPRASTHA MEDICAL/
FORTIS HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs41199 20.6%   
Low Rs29141 20.7%   
Sales per share (Unadj.) Rs72.092.1 78.2%  
Earnings per share (Unadj.) Rs3.9-0.6 -692.0%  
Cash flow per share (Unadj.) Rs6.94.4 157.7%  
Dividends per share (Unadj.) Rs1.800-  
Dividend yield (eoy) %5.10-  
Book value per share (Unadj.) Rs20.486.3 23.6%  
Shares outstanding (eoy) m91.67463.13 19.8%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.51.8 26.4%   
Avg P/E ratio x9.1-304.6 -3.0%  
P/CF ratio (eoy) x5.138.7 13.1%  
Price / Book Value ratio x1.72.0 87.3%  
Dividend payout %46.60-   
Avg Mkt Cap Rs m3,22278,802 4.1%   
No. of employees `0003.12.5 123.0%   
Total wages/salary Rs m1,4188,260 17.2%   
Avg. sales/employee Rs Th2,125.716,891.6 12.6%   
Avg. wages/employee Rs Th456.63,271.2 14.0%   
Avg. net profit/employee Rs Th114.1-102.5 -111.4%   
INCOME DATA
Net Sales Rs m6,60042,651 15.5%  
Other income Rs m1861,470 12.6%   
Total revenues Rs m6,78644,122 15.4%   
Gross profit Rs m7332,169 33.8%  
Depreciation Rs m2812,295 12.3%   
Interest Rs m961,249 7.6%   
Profit before tax Rs m54296 563.5%   
Minority Interest Rs m0-213 0.0%   
Prior Period Items Rs m0656 0.0%   
Extraordinary Inc (Exp) Rs m0-332 0.0%   
Tax Rs m187466 40.2%   
Profit after tax Rs m354-259 -137.0%  
Gross profit margin %11.15.1 218.3%  
Effective tax rate %34.6484.6 7.1%   
Net profit margin %5.4-0.6 -885.1%  
BALANCE SHEET DATA
Current assets Rs m1,47314,337 10.3%   
Current liabilities Rs m1,92014,762 13.0%   
Net working cap to sales %-6.8-1.0 679.2%  
Current ratio x0.81.0 79.0%  
Inventory Days Days75 129.1%  
Debtors Days Days3638 93.7%  
Net fixed assets Rs m2,94722,703 13.0%   
Share capital Rs m9174,631 19.8%   
"Free" reserves Rs m95567,420 1.4%   
Net worth Rs m1,87139,973 4.7%   
Long term debt Rs m2588,412 3.1%   
Total assets Rs m4,48814,337 31.3%  
Interest coverage x6.71.1 619.4%   
Debt to equity ratio x0.10.2 65.6%  
Sales to assets ratio x1.53.0 49.4%   
Return on assets %10.06.9 145.1%  
Return on equity %18.9-0.6 -2,925.8%  
Return on capital %29.93.0 994.2%  
Exports to sales %00-   
Imports to sales %1.80.2 885.6%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m11685 137.0%   
Fx inflow Rs m1,11688 1,269.4%   
Fx outflow Rs m218482 45.2%   
Net fx Rs m898-394 -227.8%   
CASH FLOW
From Operations Rs m5811,674 34.7%  
From Investments Rs m-2182,210 -9.9%  
From Financial Activity Rs m-361-4,438 8.1%  
Net Cashflow Rs m2-554 -0.4%  

Share Holding

Indian Promoters % 49.4 71.3 69.3%  
Foreign collaborators % 1.6 0.0 -  
Indian inst/Mut Fund % 1.3 0.3 433.3%  
FIIs % 0.5 9.0 5.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 47.2 19.4 243.3%  
Shareholders   38,169 110,110 34.7%  
Pledged promoter(s) holding % 0.0 82.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDRAPRASTHA MEDICAL With:   APOLLO HOSPITALS  



Today's Market

Indian Indices End Day Flat; Oil and Gas Stocks Lead Losses(Closing)

After opening the day in red, share markets in India witnessed negative trading activity throughout the day and ended the day on a weak note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDRAPRASTHA MEDICAL SHARE PRICE


Feb 22, 2018 (Close)

TRACK INDRAPRASTHA MEDICAL

  • Track your investment in INDRAPRASTHA MEDICAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDRAPRASTHA MEDICAL

INDRAPRASTHA MEDICAL - FORTIS HEALTHCARE COMPARISON

COMPARE INDRAPRASTHA MEDICAL WITH

MARKET STATS